Citation: | ZHUOBing-fan, ZHANGYan-qing, NINGXiao-yan. Effect of Tongxie Yao Fang Combined with Sijunzi Decoction on Brain-Gut Peptide in Irritable Bowel Syndrome Patients with Diarrhea Type[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(1): 25-28. |
[1] |
刘作静,魏慧,段丽萍,等.肠易激综合征患者合并小肠细菌过度生长的临床特征及利福昔明治疗效果初探[J].中华医学杂志,2016,96(24):1896-1902.
|
[2] |
樊文娟,常敏,李晓青,等.肠易激综合征患者症状特点及严重程度影响因素分析[J].中华全科医学杂志,2017,16(9):668-671.
|
[3] |
中华中医药学会脾胃病分会. 肠易激综合征中医诊疗共识意见[J]. 中华中医药杂志,2010,25(7):1062-1065.
|
[4] |
卓冰帆,宁晓燕,张彦卿. 痛泻要方合四君子汤对腹泻型肠易激综合征患者免疫功能的影响[J].广东医学,2017,38(23):3669-3675.
|
[5] |
王超,王巧民,宋继中,等.肠易激综合征患者精神心理因素对生活质量、睡眠质量以及症状严重程度的影响[J].胃肠病学,2016,21(1):34-38.
|
[6] |
HOU XH,CHEN SL,ZHANG YL, et al. Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland,Egypt,Mexico and China[J]. Clin Drug Investig, 2014,34(11):783-793.
|
[7] |
中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:233-237.
|
[8] |
WEBER HC. New treatment options for irritable bowel syndrome with predominant diarrhea[J].Curr Opin Endocrinol Diabetes Obes, 2017,24(1):25-30.
|
[9] |
杨波,陈道荣.肠易激综合征发病影响因素的研究进展[J].山东医药,2018,58(9):102-105.
|
[10] |
陆夏敏,陆敏.从脑-肠轴角度探讨肠易激综合征的中医治疗[J].河南中医,2016,36(6):1114-1116.
|
[11] |
〖JP2〗SUN JH, WU XL, MENG YF, et al. Electro-acupuncture decreases 5-HT, CGRP and increases NPY in the brain-gut axis in two rat models of Diarrhea-predominant irritable bowel syndrome(D-IBS)[J].BMC Comple Altern Med, 2015,15(1):340.〖JP〗
|
[12] |
MAO Q, SHI L,WANG ZG, et al. Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome[J].J Ethnopharmacol, 2017,201(6):123-135.
|
[13] |
侯政昆,李梅,谢地,等.肠易激综合征中医证候与神经内分泌机制的横断面临床研究[J].中国中药杂志,2016,41(7):1325-1337.
|